Market Cap 30.91M
Revenue (ttm) 0.00
Net Income (ttm) -55.92M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 118,800
Avg Vol 588,622
Day's Range N/A - N/A
Shares Out 35.13M
Stochastic %K 33%
Beta 3.03
Analysts Strong Sell
Price Target $8.71

Company Profile

Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 410 0266
Address:
11250 El Camino Real, Suite 100, San Diego, United States
TheMoneyDude777
TheMoneyDude777 May. 13 at 12:20 PM
$SKYE oh i see they deleted this comment lol “ incoming .7 fast then summer dilution and the RS”
0 · Reply
TheMoneyDude777
TheMoneyDude777 May. 13 at 12:18 PM
$SKYE this company has a zero chance to recover
0 · Reply
TheMoneyDude777
TheMoneyDude777 May. 13 at 11:26 AM
$SKYE .7 fast and RS for the summer after a dilution
0 · Reply
MissionaryTrader
MissionaryTrader May. 13 at 1:07 AM
$SKYE “Skye Bioscience price target lowered to $6 from $13 at Piper Sandler“
2 · Reply
TheMoneyDude777
TheMoneyDude777 May. 12 at 8:53 PM
$SKYE lol .80 called it lol
0 · Reply
focafoca99
focafoca99 May. 12 at 7:22 PM
$SKYE released its Q1 2026 results and business update, noting nimacimab progress and a $17.1 million cash runway.
0 · Reply
YazzJr
YazzJr May. 12 at 3:21 PM
$SKYE Their money situation is very concerning. Unfortunately, the share price is way to low for any kind of meaningful cash raise through dilution. Not sure what levers they can pull. But $17.1M will not get them far and we really wont have any news of substance until the 4th quarter. SKYE needs a partnership with some up front money or to be acquired STAT. I know they have said they have cash until the 4th quarter but, the way they go through money I don't see how they can make it through the 3rd qtr. They are going to probably need to do some kind of dilution and then hit us with a reverse split. They might be able to raise $10M that way but, that is assuming they can find investors to buy the diluted shares. They are in quite a predicament. They really need a partner BAD.
3 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 12 at 1:09 PM
$SKYE Q1 '26 Earnings Results & Recap Reported GAAP EPS of -$0.32 down -14.29% YoY
0 · Reply
Lucoz12
Lucoz12 May. 12 at 11:23 AM
$SKYE : "Skye has engaged Lilly Catalyze360 in a development consulting engagement to provide written feedback on the nimacimab target product profile, and Phase 2b trial architecture." "This engagement is a development advisory engagement and does not constitute a commitment regarding any future transaction, therapeutic interest, exclusivity or corporate business development process."
1 · Reply
TheMoneyDude777
TheMoneyDude777 May. 8 at 5:20 PM
$SKYE yes!!! come down to .8
0 · Reply
Latest News on SKYE
Skye Bioscience reports Q1 EPS (32c), consensus (32c)

2026-05-11T21:09:20.000Z - 1 day ago

Skye Bioscience reports Q1 EPS (32c), consensus (32c)


Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit

Apr 7, 2026, 7:00 AM EDT - 5 weeks ago

Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit


Skye Bioscience Earnings Call Transcript: Q4 2025

Mar 10, 2026, 4:30 PM EDT - 2 months ago

Skye Bioscience Earnings Call Transcript: Q4 2025


Skye Bioscience reports Q4 EPS (36c), consensus (31c)

2026-03-10T20:12:08.000Z - 2 months ago

Skye Bioscience reports Q4 EPS (36c), consensus (31c)


Skye Bioscience presents poster on efficacy of Nimacimab

2026-01-29T12:20:16.000Z - 3 months ago

Skye Bioscience presents poster on efficacy of Nimacimab


Skye Bioscience to Present Poster at Keystone Obesity Conference

Jan 21, 2026, 7:00 AM EST - 4 months ago

Skye Bioscience to Present Poster at Keystone Obesity Conference


Skye Bioscience provides 2026 corporate outlook

2026-01-12T12:12:34.000Z - 4 months ago

Skye Bioscience provides 2026 corporate outlook


Skye Provides 2026 Corporate Outlook

Jan 12, 2026, 7:00 AM EST - 4 months ago

Skye Provides 2026 Corporate Outlook


Skye Bioscience Earnings Call Transcript: Q3 2025

Nov 10, 2025, 4:30 PM EST - 6 months ago

Skye Bioscience Earnings Call Transcript: Q3 2025


Skye Bioscience reports Q3 EPS (32c), consensus (32c)

2025-11-10T21:16:34.000Z - 6 months ago

Skye Bioscience reports Q3 EPS (32c), consensus (32c)


Skye Bioscience downgraded to Hold from Buy at Craig-Hallum

2025-10-06T16:15:27.000Z - 7 months ago

Skye Bioscience downgraded to Hold from Buy at Craig-Hallum


Why Is Skye Bioscience Stock Down 60% Today?

2025-10-06T12:19:20.000Z - 7 months ago

Why Is Skye Bioscience Stock Down 60% Today?


Skye Bioscience Transcript: Study Update

Oct 6, 2025, 8:00 AM EDT - 7 months ago

Skye Bioscience Transcript: Study Update


Skye Bioscience Transcript: KOL Event

Sep 4, 2025, 8:00 AM EDT - 8 months ago

Skye Bioscience Transcript: KOL Event


Skye Bioscience Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 9 months ago

Skye Bioscience Earnings Call Transcript: Q2 2025


TheMoneyDude777
TheMoneyDude777 May. 13 at 12:20 PM
$SKYE oh i see they deleted this comment lol “ incoming .7 fast then summer dilution and the RS”
0 · Reply
TheMoneyDude777
TheMoneyDude777 May. 13 at 12:18 PM
$SKYE this company has a zero chance to recover
0 · Reply
TheMoneyDude777
TheMoneyDude777 May. 13 at 11:26 AM
$SKYE .7 fast and RS for the summer after a dilution
0 · Reply
MissionaryTrader
MissionaryTrader May. 13 at 1:07 AM
$SKYE “Skye Bioscience price target lowered to $6 from $13 at Piper Sandler“
2 · Reply
TheMoneyDude777
TheMoneyDude777 May. 12 at 8:53 PM
$SKYE lol .80 called it lol
0 · Reply
focafoca99
focafoca99 May. 12 at 7:22 PM
$SKYE released its Q1 2026 results and business update, noting nimacimab progress and a $17.1 million cash runway.
0 · Reply
YazzJr
YazzJr May. 12 at 3:21 PM
$SKYE Their money situation is very concerning. Unfortunately, the share price is way to low for any kind of meaningful cash raise through dilution. Not sure what levers they can pull. But $17.1M will not get them far and we really wont have any news of substance until the 4th quarter. SKYE needs a partnership with some up front money or to be acquired STAT. I know they have said they have cash until the 4th quarter but, the way they go through money I don't see how they can make it through the 3rd qtr. They are going to probably need to do some kind of dilution and then hit us with a reverse split. They might be able to raise $10M that way but, that is assuming they can find investors to buy the diluted shares. They are in quite a predicament. They really need a partner BAD.
3 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 12 at 1:09 PM
$SKYE Q1 '26 Earnings Results & Recap Reported GAAP EPS of -$0.32 down -14.29% YoY
0 · Reply
Lucoz12
Lucoz12 May. 12 at 11:23 AM
$SKYE : "Skye has engaged Lilly Catalyze360 in a development consulting engagement to provide written feedback on the nimacimab target product profile, and Phase 2b trial architecture." "This engagement is a development advisory engagement and does not constitute a commitment regarding any future transaction, therapeutic interest, exclusivity or corporate business development process."
1 · Reply
TheMoneyDude777
TheMoneyDude777 May. 8 at 5:20 PM
$SKYE yes!!! come down to .8
0 · Reply
TheMoneyDude777
TheMoneyDude777 May. 8 at 3:44 PM
$SKYE yeh cone to .8
0 · Reply
TheMoneyDude777
TheMoneyDude777 May. 8 at 2:09 PM
$SKYE huh i want this at .8 i have a bad feeling its about to jump to $2-3 suddenly. waters are to calm
0 · Reply
TheMoneyDude777
TheMoneyDude777 May. 8 at 2:08 AM
$SKYE awesome drop .8 incoming
0 · Reply
Fellforit
Fellforit May. 8 at 1:24 AM
$SKYE congrats missionary...with your added, added, added, etc. etc. todays .048 cents must have made you a multi multi millionaire--or is it dhillionaire??
0 · Reply
MissionaryTrader
MissionaryTrader May. 7 at 8:01 PM
$SKYE bullish
0 · Reply
Jangalang
Jangalang May. 6 at 4:37 PM
$SKYE … dead room, dead stock, dead money. Run far away from this dying company.
1 · Reply
Jangalang
Jangalang May. 6 at 4:36 PM
$SKYE … I have been holding this so long that I’ve seen the ticker symbol change at least four or five times along with the same amount of reverse splits. This company is absolute garbage. This will go down in history as one of the worst investments of my life. Run far away from this dead stock.
0 · Reply
Fellforit
Fellforit May. 6 at 4:13 PM
$SKYE why complain? Some on here look at this as prime buying opportunities!! every day!! HILARIOUS..
0 · Reply
TheMoneyDude777
TheMoneyDude777 May. 6 at 4:07 PM
$SKYE awesome.8 close please
0 · Reply
TheMoneyDude777
TheMoneyDude777 May. 6 at 11:05 AM
$SKYE down to .83
0 · Reply
TheMoneyDude777
TheMoneyDude777 May. 5 at 10:06 PM
$SKYE yep worst company ever!
0 · Reply
TheMoneyDude777
TheMoneyDude777 May. 5 at 10:04 PM
$SKYE this will never close over a dollar again. here we coming pink list!!!! or RS
0 · Reply